search tools

European Commission Approves Bristol-Myers Squibb's Opdivo® (nivolumab) for Previously Treated Advanced Renal Cell Carcinoma (188KB) (ONO Pharmaceutical Co Ltd)

Edit Public Technologies 08 Apr 2016
Bristol-Myers Squibb (BMS) has a robust clinical ... In Japan, ONO and BMS (and BMS Japan subsidiary BMSKK) have formed a strategic partnership that includes co-development, co-commercialization, and co-promotion of multiple immunotherapies for patients with cancer. Attached from the following page is the press release made by BMS for your information....

Sterile connecting device by Wuhan-based company through CE certification (Wuhan Municipal Government)

Edit Public Technologies 08 Apr 2016
The sterile connecting devices of blood, produced and developed by the bms Medical Technologies GmbH in Wuhan (hereinafter referred to as 'bms China'), claimed European CE Certification recently, local media said on April 5, 2016 ... The sterile connecting devices by bms China ......

Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc. (Compugen Ltd)

Edit Public Technologies 07 Apr 2016
When at BMS, Dr ... Elliott Sigal is a former Executive Vice President and Director of Bristol-Myers Squibb, and served as Chief Scientific Officer and President of R&D for BMS from 2004 until 2013 ... Among his accomplishments in various therapeutic areas was building BMS research into a lead position in the promising area of immuno-oncology....

Bristol-Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) in Combination with Yervoy® (ipilimumab) for Treatment of Advanced Melanoma (139KB) (ONO Pharmaceutical Co Ltd)

Edit Public Technologies 06 Apr 2016
Bristol-Myers Squibb (BMS) has a robust clinical ... In Japan, ONO and BMS (and BMS Japan subsidiary BMSKK) have formed a strategic partnership that includes co-development, co-commercialization, and co-promotion of multiple immunotherapies for patients with cancer. Attached from the following page is the press release made by BMS for your information....

European Commission Approves Bristol-Myers Squibb’s Opdivo® (nivolumab) for Previously Treated Advanced Renal Cell Carcinoma (Bristol-Myers Squibb Company)

Edit Public Technologies 06 Apr 2016
(Source. Bristol-Myers Squibb Company) ... This approval allows for the expanded marketing of Opdivo in previously treated advanced RCC in all 28 Member States of the European Union ... Dr ... 21-29.6] vs ... U.S ... For more information about Bristol-Myers Squibb, visit us at www.bms.com or follow us on LinkedIn, Twitter, and YouTube ... http.//news.bms.com/press-release/european-commission-approves-bristol-myers-squibbs-opdivo-nivolumab-previously-treated....

European Commission Approves Expanded Use of Opdivo® (nivolumab) to Include Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer (Bristol-Myers Squibb Company)

Edit Public Technologies 06 Apr 2016
(Source. Bristol-Myers Squibb Company) ... Together, these trials confirm the benefit of Opdivo for patients with previously treated metastatic NSCLC, regardless of PD-L1 expression ... 33.3-44.6) ... U.S ... In ... For more information about Bristol-Myers Squibb, visit us at www.bms.com or follow us on LinkedIn, Twitter, and YouTube ... http.//news.bms.com/press-release/european-commission-approves-expanded-use-opdivo-nivolumab-include-previously-treated-....

Asseco at Cybersec PL (Asseco Poland SA)

Edit Public Technologies 05 Apr 2016
(Source. Asseco Poland SA). Asseco will take part in the Cybersec PL conference to be held in Warsaw on 8 April. The objective of the meeting is to strengthen the national system of cybersecurity and conduct effective actions in cyberspace ... In 2015, Asseco Poland has become a member of the 'BMS Consortium' that is going to offer a technologically advanced Battlefield Management System (BMS) ... Original Document ... (noodl....

Anganwadi workers' stir hits BPL families

Edit The Times of India 05 Apr 2016
Ranchi/Jamshedpur/Bokaro. The anganwadi workers' strike, which has led to the closure of around 38,432 anganwadi centres across the state, has affected food and preparatory education for children and distribution of ready-to-eat food for pregnant and lactating mothers ... However, around 1722 anganwadi centres in Jamshedpur, which are affiliated to Bharatiya Mazdoor Sangh (BMS) and have not supported the strike, are running smoothly ... ....

Success stories in medical technology (Friwo AG)

Edit Public Technologies 05 Apr 2016
(Source. Friwo AG). 30. March 2016. Developments of the medical and pharmaceutical industry progress continually and allow a better and more gentle treatment of patients. Technological focus is placed on medical devices which have become an integral part of today's diagnostics and therapy ... infusion pumps ... In addition, our smart battery management systems (BMS) allows a permanent data exchange and continuous monitoring of the battery ... (noodl....

Fitch Downgrades Rolta India to 'B'; Outlook Negative (Fitch Inc)

Edit Public Technologies 05 Apr 2016
(Source. Fitch Inc). 05 Apr 2016 4.12 AM EST. Fitch Ratings-Singapore-05 April 2016 ... The Outlook is Negative ... Rolta's financial profile could receive boost in 2018-2019 if it implements the Indian defence ministry's battlefield management system (BMS) order in partnership with state-owned Bharat Electronics Limited (BEL) ... 13%) as it will need to invest in developing prototypes for the Indian BMS systems and other regular IT orders ... (noodl....

2016, Apr 05 - New Skydrol packaging for improved customer experience (Eastman Chemical Company)

Edit Public Technologies 05 Apr 2016
(Source. Eastman Chemical Company). Kingsport, TN, April,5, 2016- Eastman Chemical Company has unveiled a new, updated packaging design for their line of Skydrol Hydraulic Fluids. The transition to this more user-friendly packaging will begin in May of 2016 ... The Eastman Skydrol Hydraulic Fluid products themselves will not change ... Skydrol 5 was the first Type V fluid qualified under the Boeing BMS 3-11 specification ... Media Contact. ... (noodl....

ONO PHARMA KOREA Receives Approval for OPDIVO® (Nivolumab) for Expanded Application of Unresectable or Metastatic Melanoma and Additional Indication of Locally Advanced or Metastatic Non-small Cell Lung Cancer Refractory to Existing Chemotherapy in South Korea (90.2KB) (ONO Pharmaceutical Co Ltd)

Edit Public Technologies 04 Apr 2016
Outside of Japan, Bristol Myers Squibb ("BMS"), with whom ONO collaborates in Japan, South Korea and Taiwan, currently has regulatory approval for OPDIVO in 48 countries globally ... In 2011, through the collaboration agreement with BMS, ONO granted BMS exclusive rights to develop and commercialize OPDIVO globally except in Japan, South Korea and Taiwan, where ONO had retained all rights to the compound at the time....

Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement with Daiichi Sankyo to Develop Andexanet Alfa with ...

Edit Stockhouse 04 Apr 2016
This agreement follows recent agreements with Bristol-Myers Squibb (BMS), Pfizer Inc ... Under those agreements, BMS and Pfizer will be responsible for development, regulatory and commercial activities for andexanet alfa in Japan ... In Japan, three oral Factor Xa inhibitors are currently on the market – Daiichi Sankyo’s edoxaban, BMS and Pfizer’s apixaban, and Bayer HealthCare’s rivaroxaban....
×
×
×
×